Accuray Share Price (NASDAQ: ARAY)

$1.5

▲

-0.12

(-7.41%)

Last updated on August 20, 2025 at 8:42 PM IST

$₹

Check the interactive Accuray Stock chart to analyse performance

Accuray stock performance

as on August 20, 2025 at 8:42 PM IST

Today's Low:$1.50
Today's High:$1.60
$1.50
0.0%
Downside
Day's Volatility :6.25%
Upside
6.25%
52 Weeks Low:$1.14
52 Weeks High:$2.95
$1.50
23.99%
Downside
52 Weeks Volatility :61.35%
Upside
49.15%

Accuray Stock Returns

Period	Accuray Incorporated	Sector (Health Care)	Index (Russel 2000)
3 Months	-7.1%	1.5%	0.0%
6 Months	-33.11%	-7.1%	0.0%
1 Year	-33.7%	-11.4%	0.0%
3 Years	-42.56%	2.9%	-9.6%

Accuray Incorporated Key Stats

Check Accuray key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$1.51
Open	$1.58
Today's High	$1.51
Today's Low	$1.48
Market Capitalization	$155.5M
Today's Volume	$1.0M
52 Week High	$2.95
52 Week Low	$1.1401
Revenue TTM	$458.5M
EBITDA	$13.9M
Earnings Per Share (EPS)	$-0.02
Profit Margin	-0.35%
Quarterly Earnings Growth YOY	-0.96%
Return On Equity TTM	-2.52%

Stock Returns calculator for Accuray Stock including INR - Dollar returns

The Accuray stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Accuray investment value today

Current value as on today

₹69,867

Returns

₹30,133

(-30.13%)

Returns from Accuray Stock

₹33,921 (-33.92%)

Dollar Returns*

₹3,788 (+3.79%)

Indian investors sentiment towards Accuray Stock

-22.5%

Period: Jul 20, 2025 to Aug 19, 2025. Change in 30 Days versus previous period

Investment in Accuray Shares from India has dropped by -22.5% over the past 30 days, indicating reduced transactional activity.

-9%

Period: Jul 20, 2025 to Aug 19, 2025. Change in 30 Days versus previous period

Search interest for Accuray Stock from India on INDmoney has decreased by -9% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Accuray Incorporated

Name
Holdings %
Name
Holdings %
BlackRock Inc
8.67%
Neuberger Berman Group LLC
5.36%
Vanguard Group Inc
5.21%
Heartland Advisors Inc
4.91%
Renaissance Technologies Corp
2.64%
Armistice Capital, LLC
2.46%

Analyst Recommendation on Accuray Stock

Rating

Trend

Buy

90%Buy

10%Hold

0%Sell

Based on 10 Wall street analysts offering stock ratings for Accuray(by analysts ranked 0 to 5 stars)

Accuray Share Price Target

What analysts predicted

Upside of 266.67%

Target:

$5.50

Current:

$1.50

Accuray share price target is $5.50, a slight Upside of 266.67% compared to current price of $1.50 as per analysts' prediction.

Accuray Stock Insights

Price Movement
In the last 1 month, ARAY stock has moved up by 12.7%
Increasing Revenue
Revenue is up for the last 2 quarters, 113.24M → 127.54M (in $), with an average increase of 11.2% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -1.29M → 1.12M (in $), with an average increase of 215.5% per quarter

Accuray Incorporated Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY20

FY21

FY22

FY23

FY24

FY25

	FY20	Y/Y Change
Revenue	$382.9M	↓ 8.56%
Net Income	$3.8M	↓ 123.29%
Net Profit Margin	1.0%	↑ 4.92%

	FY21	Y/Y Change
Revenue	$396.3M	↑ 3.49%
Net Income	$-6.3M	↓ 264.91%
Net Profit Margin	-1.59%	↓ 2.59%

	FY22	Y/Y Change
Revenue	$429.9M	↑ 8.48%
Net Income	$-5.3M	↓ 15.27%
Net Profit Margin	-1.24%	↑ 0.35%

	FY23	Y/Y Change
Revenue	$447.6M	↑ 4.12%
Net Income	$-9.3M	↑ 73.56%
Net Profit Margin	-2.07%	↓ 0.83%

	FY24	Y/Y Change
Revenue	$446.6M	↓ 0.24%
Net Income	$-15.5M	↑ 67.51%
Net Profit Margin	-3.48%	↓ 1.41%

	FY25	Y/Y Change
Revenue	$458.5M	↑ 2.68%
Net Income	$-1.6M	↓ 89.77%
Net Profit Margin	-0.35%	↑ 3.13%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$101.1M	↓ 5.69%
Net Income	$-6.3M	↓ 34.08%
Net Profit Margin	-6.27%	↑ 2.7%

	Q2 FY24	Q/Q Change
Revenue	$134.3M	↑ 32.79%
Net Income	$3.4M	↓ 153.41%
Net Profit Margin	2.52%	↑ 8.79%

	Q3 FY24	Q/Q Change
Revenue	$101.5M	↓ 24.38%
Net Income	$-4.0M	↓ 216.74%
Net Profit Margin	-3.89%	↓ 6.41%

	Q4 FY24	Q/Q Change
Revenue	$116.2M	↑ 14.41%
Net Income	$2.5M	↓ 164.16%
Net Profit Margin	2.18%	↑ 6.07%

	Q1 FY25	Q/Q Change
Revenue	$113.2M	↓ 2.52%
Net Income	$-1.3M	↓ 151.12%
Net Profit Margin	-1.15%	↓ 3.33%

	Q2 FY25	Q/Q Change
Revenue	$127.5M	↑ 12.63%
Net Income	$1.1M	↓ 186.58%
Net Profit Margin	0.88%	↑ 2.03%

FY20

FY21

FY22

FY23

FY24

FY25

	FY20	Y/Y Change
Profit	$149.9M	↓ 7.86%

	FY21	Y/Y Change
Profit	$159.5M	↑ 6.43%

	FY22	Y/Y Change
Profit	$160.0M	↑ 0.28%

	FY23	Y/Y Change
Profit	$154.0M	↓ 3.75%

	FY24	Y/Y Change
Profit	$142.9M	↓ 7.17%

	FY25	Y/Y Change
Profit	$147.0M	↑ 2.83%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$29.1M	↓ 19.02%

	Q2 FY24	Q/Q Change
Profit	$38.5M	↑ 32.26%

	Q3 FY24	Q/Q Change
Profit	$34.5M	↓ 10.36%

	Q4 FY24	Q/Q Change
Profit	$41.9M	↑ 21.54%

	Q1 FY25	Q/Q Change
Profit	$31.6M	↓ 24.5%

	Q2 FY25	Q/Q Change
Profit	$39.0M	↑ 23.25%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-29.6M	↓ 261.7%
Investing Cash Flow	$-4.3M	↓ 124.27%
Financing Cash Flow	$28.5M	↓ 203.72%

	FY20	Y/Y Change
Operating Cash Flow	$-1.5M	↓ 95.04%
Investing Cash Flow	$-3.7M	↓ 13.52%
Financing Cash Flow	$26.7M	↓ 6.24%

	FY21	Y/Y Change
Operating Cash Flow	$38.5M	↓ 2721.65%
Investing Cash Flow	$-2.4M	↓ 35.65%
Financing Cash Flow	$-28.8M	↓ 207.9%

	FY22	Y/Y Change
Operating Cash Flow	$-2.4M	↓ 106.23%
Investing Cash Flow	$-4.7M	↑ 96.62%
Financing Cash Flow	$-15.4M	↓ 46.64%

	FY23	Y/Y Change
Operating Cash Flow	$15.5M	↓ 747.46%
Investing Cash Flow	$-12.7M	↑ 168.84%
Financing Cash Flow	$-2.1M	↓ 86.26%

	FY24	Y/Y Change
Operating Cash Flow	$-11.9M	↓ 176.61%
Investing Cash Flow	$-3.6M	↓ 71.6%
Financing Cash Flow	$-4.0M	↑ 87.07%

Q4 FY23

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

	Q4 FY23	Q/Q Change
Operating Cash Flow	$-5.1M	↓ 40.72%
Investing Cash Flow	$-1.2M	↑ 14.38%
Financing Cash Flow	$-257.0K	↓ 82.87%

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-8.1M	↑ 59.08%
Investing Cash Flow	$-795.0K	↓ 36.35%
Financing Cash Flow	$-1.5M	↑ 483.66%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$9.9M	↓ 221.97%
Investing Cash Flow	$-465.0K	↓ 41.51%
Financing Cash Flow	$-694.0K	↓ 53.73%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-7.3M	↓ 173.81%
Investing Cash Flow	$-1.1M	↑ 140.86%
Financing Cash Flow	$-2.2M	↑ 213.11%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$1.8M	↓ 124.69%
Investing Cash Flow	$-1.6M	↑ 40.18%
Financing Cash Flow	$5.8M	↓ 365.35%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$18.1M	↑ 902.83%
Investing Cash Flow	$-2.4M	↑ 54.84%
Financing Cash Flow	$-2.0M	↓ 134.69%

Accuray Technicals Summary

Sell

Neutral

Buy

Accuray is currently in a neutral trading position according to technical analysis indicators.

Accuray Incorporated Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Accuray Incorporated	12.31%	-33.11%	-33.7%	-42.56%	-37.81%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Accuray Incorporated	0.0	NA	0.08	-0.03	-0.03	0.01	NA	0.76

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Accuray Incorporated	Buy	$155.5M	-37.81%	0.0	-0.35%

About Accuray Incorporated

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.

Organization	Accuray
Employees	0
CEO	Ms. Suzanne Winter M.B.A.
Industry	Health Technology

Key Management of Accuray Incorporated

Name	Title
Ms. Suzanne Winter M.B.A.	President, CEO & Director
Mr. Jesse Chew J.D.	Senior VP, Chief Legal Officer & Company Secretary
Mr. Sandeep Chalke	Senior VP & Chief Commercial Officer
Mr. Leonel Peralta	Senior VP & Chief Operations Officer
Mr. Michael J. Murphy CPA	Principal accounting officer
Mr. John M. Dunn	Senior VP, Chief Information & Security Officer
Beth Kaplan	Public Relations Director
Ms. Melanie Rivers	Senior VP, Chief Human Resources Officer
Mr. Jim Dennison	Senior VP and Chief Quality & Development Officer
Dr. Seth Blacksburg M.B.A., M.D.	Senior VP & Chief Medical Officer

Important FAQs about investing in ARAY Stock from India :

What is Accuray share price today?

Accuray share price today is $1.50 as on August 20, 2025 at 8:42 PM IST at the close of the market. Accuray share today touched a day high of $1.60 and a low of $1.50.

What is the 52 week high and 52 week low for Accuray share?

Accuray share touched a 52 week high of $2.95 and a 52 week low of $1.14. Accuray stock price today i.e. August 20, 2025 at 8:42 PM IST is closed at $1.50, lower by 49.15% versus the 52 week high.

How to invest in Accuray Stock (ARAY) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Accuray on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Accuray Shares that will get you 1.0000 shares as per Accuray share price of $1.50 per share as on August 20, 2025 at 8:42 PM IST.

What is the minimum amount required to buy Accuray Stock (ARAY) from India?

Indian investors can start investing in Accuray (ARAY) shares with as little as ₹86.938 or $1 (as of August 20, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹869.38 in Accuray stock (as per the Rupee-Dollar exchange rate as on August 20, 2025). Based on Accuray share’s latest price of $1.50 as on August 20, 2025 at 8:42 PM IST, you will get 6.6667 shares of Accuray. Learn more about fractional shares .

What are the returns that Accuray has given to Indian investors in the last 5 years?

Accuray stock has given -37.81% share price returns and 16.15% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?